Literature DB >> 23423662

Influence of a moderate physical activity intervention on red cell deformability in patients suffering from chronic obstructive pulmonary disease (COPD).

Basit Ahmad1, Nina Ferrari, Georgina Montiel, Wilhelm Bloch, Anke Raabe-Oetker, Nina Skrobala, Klara Brixius.   

Abstract

The present study investigates whether a moderate physical activity intervention may alter red cell deformability (RCD) of patients suffering from chronic obstructive pulmonary disease (COPD). Subjects (n = 10; age: 62 ± 4; body-mass index (BMI): 25.8 ± 7.5) performed a training regimen for 10 weeks. In the beginning of the study and after the training period, COPD patients underwent a WHO cycle ergometry test. Venous blood samples were taken before (T0), immediately after (T1) and 30 min after (T2) the intervention. RCD was measured with the laser-assisted optical rotational cell analyzer (LORCA). Significant improvements of the RCD were detected. The semi-maximal shear stress increased significantly. Acute exhaustion had no effect on RCD. Thus, the training period of 10 weeks influenced RCD.

Entities:  

Mesh:

Year:  2013        PMID: 23423662     DOI: 10.1007/s10354-013-0183-7

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  60 in total

1.  Cardiovascular dynamics during exercise are related to blood rheology.

Authors:  Michael J Simmonds; Julien Tripette; Surendran Sabapathy; Sonya M Marshall-Gradisnik; Philippe Connes
Journal:  Clin Hemorheol Microcirc       Date:  2011       Impact factor: 2.375

2.  The erythrosense as a real-time biomarker to reveal the presence of enhanced red blood cell aggregability in atherothrombosis.

Authors:  Ori Rogowski; Shlomo Berliner; David Zeltser; Jack Serov; Einor Ben-Assayag; Daniel Justo; Meirav Rozenblat; Anat Kessler; Varda Deutsch; Vera Zakuth; Itzhak Shapira
Journal:  Am J Ther       Date:  2005 Jul-Aug       Impact factor: 2.688

Review 3.  Pulmonary rehabilitation for chronic obstructive pulmonary disease.

Authors:  Y Lacasse; R Goldstein; T J Lasserson; S Martin
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

4.  Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders.

Authors:  A L Hamilton; K J Killian; E Summers; N L Jones
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

5.  Red blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertension.

Authors:  G Cicco; A Pirrelli
Journal:  Clin Hemorheol Microcirc       Date:  1999       Impact factor: 2.375

6.  Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study.

Authors:  Andrea S Gershon; Laura Warner; Paul Cascagnette; J Charles Victor; Teresa To
Journal:  Lancet       Date:  2011-09-10       Impact factor: 79.321

Review 7.  New insights into the immunology of chronic obstructive pulmonary disease.

Authors:  Guy G Brusselle; Guy F Joos; Ken R Bracke
Journal:  Lancet       Date:  2011-09-10       Impact factor: 79.321

8.  Red cell macrocytosis in hypoxemic patients with chronic obstructive pulmonary disease.

Authors:  Argirios E Tsantes; Stefanos I Papadhimitriou; Stergios T Tassiopoulos; Stefanos Bonovas; George Paterakis; Ioannis Meletis; Dimitrios Loukopoulos
Journal:  Respir Med       Date:  2004-11       Impact factor: 3.415

9.  Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.

Authors:  S Bernard; P LeBlanc; F Whittom; G Carrier; J Jobin; R Belleau; F Maltais
Journal:  Am J Respir Crit Care Med       Date:  1998-08       Impact factor: 21.405

10.  Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD.

Authors:  F Maltais; A A Simard; C Simard; J Jobin; P Desgagnés; P LeBlanc
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

View more
  1 in total

1.  Impaired Hemorheology in Exacerbations of COPD.

Authors:  Erhan Ugurlu; Emine Kilic-Toprak; Ilknur Can; Ozgen Kilic-Erkek; Goksel Altinisik; Melek Bor-Kucukatay
Journal:  Can Respir J       Date:  2017-09-27       Impact factor: 2.409

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.